N/A N=146 Intraoperative Radiographic Detection of Retained Surgical Sponges
Surgical Sponge, Retained
Primary: Accuracy — 0.76; 0.73; 0.80 Cohen's Kappa
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=50 RF Surgical Sponge-Detecting System on the Function of Pacemakers and Implantable Cardioverter Defibrillators
Cardiomyopathy · Cardiac Arrhythmia · Heart Failure
Primary: Pacing Mode Changes Between Permanent Pacemakers (PPMs)/Implantable Cardiac Defibrillators (ICDs) Scanned With RF Assure — 29; 29; 8; 8 participants — p=1.0
N/A N=34 SERI® Surgical Scaffold for Soft Tissue Support in Revision Augmentation Surgery
Subjects Requiring Revision Breast Augmentation Surgery
Primary: Reoperation Rate (Per Implanted Breast) for the Presenting Condition at 12 Months. — 0; 0 Implanted breasts
Phase 2 N=226 Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge
Paranasal Sinus Disease
Primary: Rate of Infection — 113; 113 Participants
Phase 2 N=95 The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device
Primary Open Angle Glaucoma
Primary: Complication Rates — 29; 28 Participants — p=0.7
N/A N=109 Wound Infection Alexis Wound Retractor
Appendicitis
Primary: Post-operative Wound Infection, After Open Appendectomy — 1; 7 Participants
N/A N=301 Self-Retaining Retractor in Obese Patients Undergoing Cesarean Section
Pregnancy · Obese
Primary: Wound Infection or Disruption — 38; 37 participants
N/A N=103 SURGICEL® Powder in Controlling Mild or Moderate Parenchymal or Soft Tissue Intraoperative Bleeding in Adult Subjects
Hemorrhage
Primary: Haemostatic Success at 5 Minutes — 90 Participants
N/A N=702 Prospective, Randomized, Parallel-arm Clinical Trial of CleanCision or Alexis O in Elective Colorectal Surgery
Colorectal Surgery
Primary: Surgical Site Infection (SSI) Rate — 16; 14; 6; 1 Participants
N/A N=139 The SERI® Surgical Scaffold Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery
Breast Reconstruction
Primary: Investigator Satisfaction Following Use of SERI® Surgical Scaffold at 6 Months — 9.4 units on a scale
N/A N=1,064 Effect of Prophylactic Negative Pressure Versus Silver Impregnated Silicone Bandage on C-Section Infection Rates
D001458 · D011247
Primary: Infection Rate — 17; 18; 5; 5 Participants
Phase 3 N=721 A Study of Fibrocaps™ in Surgical Bleeding
Mild or Moderate Surgical Bleeding
Primary: Time to Hemostasis (TTH) for Participants Receiving Spinal Surgery — 1.0; 2.5 minutes — p=< 0.0001
Phase 2 N=104 Trial of Drain Antisepsis After Tissue Expander Breast Reconstruction
Nonmalignant Breast Conditions · Breast Cancer
Primary: Number of Subjects With Drain Bulb Fluid Bacterial Colonization at Approximately 1 Week — 10; 21 participants — p=0.02
Phase 3 N=602 A Study of an Antibiotic Implant in General Surgical Subjects at Higher Risk for Surgical Wound Infection
Colorectal Surgery · Surgical Wound Infection
Primary: Number of Participants With Surgical Wound Infections From Surgery Through Post-operative Day 60 — 90; 63 Participants
N/A N=234 The SURGICEL® Powder Mild or Moderate Parenchymal or Soft Tissue Intraoperative Bleeding (China Study)
Hemorrhage
Primary: Hemostatic Success at 5 Minutes — 109; 103 Participants — p=<0.0001
N/A N=9 SurgiMend Mesh at the Hiatus
Hiatal Hernia
Primary: Recurrence Rate — 6; 3 Participants
N/A N=242 A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus
Barrett Esophagus
Primary: Number of Subjects That Would Have This Procedure Again — 19; 16 Participants
Phase 4 N=550 Subcuticular Suture for Cesarean Skin Incision Closure
Complications; Cesarean Section · Surgical Wound Infection
Primary: Number of Participants With Wound Complications (Surgical Site Infection (SSI), Hematoma, Separation, Seroma, Etc) — 23; 37; 16; 25 Participants — p=0.04
N/A N=22 Surgicel Snow in Gynecological Surgery
Laparoscopic Hysterectomy
Primary: Change in Bleeding at Specified Time Intervals — 485.7; 199.1 seconds
Phase 3 N=1,502 Safety and Efficacy of an Antibiotic Implant in Cardiac Surgical Subjects at Higher Risk for Sternal Wound Infection
Cardiac Surgery · Sternal Wound Infection
Primary: Number of Participants With Surgical Wound Infections From Surgery Through Post-operative Day 90 — 63; 65 Participants
N/A N=204 Permanent Versus Absorbable Colpopexy Trial
Pelvic Organ Prolapse
Primary: Number of Participants With Vaginal Mesh or Suture Exposure — 5; 8 Participants — p=0.30
N/A N=60 Prospective Randomized Trial of Stratafix vs. Vicryl in Total Hip Arthroplasty.
Wound; Hip
Primary: Time to Close, Minutes — 18.0; 21.0 minutes
N/A N=44 A Randomized Controlled Trial of Permanent vs Absorbable Suture for Uterosacral Ligament Suspension
Pelvic Organ Prolapse · Cystocele · Uterine Prolapse
Primary: Pelvic Organ Prolapse Quantification Exam (POP-Q) Point C — -7.25; -7 cm
N/A N=298 Prevena™ Incisional Negative Pressure Wound Therapy in Re-operative Colorectal Surgery
Surgical Site Infection
Primary: Occurrence of Superficial Surgical Site Infection — 11; 21; 107; 128 Participants
N/A N=242 Validating a New Method to Assess Estimated Blood Loss in the Obstetric Population
Pregnancy Complications
Primary: Clinical Estimated Blood Loss (EBL) Between Cases and Controls Using Clinical Estimate Versus Device Assessment — 800; 800 milliLiters
N/A N=491 Urinary Retention After Laparoscopic Inguinal Hernia Repair: Comparing the Use of the Intraoperative Urinary Catheter
Inguinal Hernia
Primary: Number of Participants With Post Operative Urinary Retention — 23; 21 Participants
N/A N=300 Air Barrier System for the Prevention of Surgical Site Infection
Surgical Site Infection
Primary: Incidence of Implant Infection (Number of Occurrences in Each Arm). — 4; 0 Participants — p=0.067
Phase 4 N=150 The Impact of Retropubic Lidocaine vs Saline on Postoperative Urinary Retention Following Midurethral Sling
Stress Urinary Incontinence
Primary: Number of Subjects With Urinary Retention — 15; 14 Participants
Phase 4 N=97 Evaluation of an Absorbable Surgical Hemostatic Agent: Thrombi-Gel® Versus Gelfoam-Thrombin
Operation Site Bleed
Primary: The Primary Objective of This Investigation is to Gather Information to Support the Effectiveness of Thrombi-Gel as Compared to a Gelatin Sponge (Gelfoam) Plus Thrombin…
N/A N=124 Comparison Between Wound Vacuum Dressing and Standard Closure to Reduce Rates of Surgical Site Infections
Surgical Site Infection · Pancreatic Neoplasms · Pancreatic Cancer
Primary: Rate of Surgical Site Infection — 6; 19 Participants — p=0.003